AGP Picks
View all

AGP Executive Report

Last update: an hour ago

Medical Access & Rights: Guinea-Bissau opposition leader Domingos Simões Pereira was released from prison to travel to Portugal for medical treatment after court-ordered humanitarian grounds, with Portuguese authorities confirming his arrival in Lisbon; his family says he was freed under international pressure, while the junta cites alleged coup involvement and health assessments say treatment couldn’t be properly done in Guinea-Bissau. Health & Climate: A new Nature study finds climate change is shifting malaria risk across sub-Saharan Africa—slightly increasing malaria overall, but reducing cases in today’s hottest West African hotspots while raising risk in southern and East Africa as temperatures climb. Regional Environment & Health Links: Wetlands International launched Mangrove Capital Africa Phase IV in Freetown, targeting mangrove restoration along Senegal–Guinea-Bissau–Sierra Leone coastal corridors to support community resilience and healthier ecosystems. Women’s Health & Protection: Campaigners in The Gambia warn progress against female genital mutilation is under threat as a Supreme Court case could overturn the 2015 ban, with renewed harassment reported against survivors.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

No AGP Wire articles available right now.


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
World Reuters Guinea-Bissau's imprisoned opposition leader allowed to travel for medical treatment

World Reuters Guinea-Bissau's imprisoned opposition leader allowed to travel for medical treatment

The struggle to end female genital mutilation: progress under threat

The struggle to end female genital mutilation: progress under threat


fallback image
Feb. 22, 2026

Guinea-Bissau Stops Trump-Backed Hepatitis B Vaccine Study

MENAFN

fallback image
Feb. 22, 2026

Guinea-Bissau Stops US-Funded Hepatitis B Vaccine Trial

MENAFN

fallback image
Feb. 25, 2026

STAND UP FOR SCIENCE: CDC-FUNDED HEPATITIS B STUDY IN GUINEA-BISSAU CANCELLED

EIN Presswire

fallback image
Feb. 17, 2026

STAND UP FOR SCIENCE CONDEMNS U.S.-FUNDED HEPATITIS B STUDY IN GUINEA-BISSAU

EIN Presswire

fallback image
Jan. 13, 2026

SOMAÍ and Universidade Lusófona Publish Peer-Reviewed Study Validating Full-Spectrum Oil Consistency

EIN Presswire

More press releases

Video Stories

YouTube video thumbnail: Number of Malawians Traveling to South Africa Drops by Half
Play
Number of Malawians Traveling to South Africa Drops by Half
YouTube video thumbnail: DR Congo Court Approves Referendum law, Fueling Third-Term Debate
Play
DR Congo Court Approves Referendum law, Fueling Third-Term Debate
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: Equatorial Guinea and Gabon Resolve 50-Year Border Dispute
Play
Equatorial Guinea and Gabon Resolve 50-Year Border Dispute
YouTube video thumbnail: Morocco's Cannabis Reform: Why Small Farmers are Left Behind
Play
Morocco's Cannabis Reform: Why Small Farmers are Left Behind

Video Title

Sign up for:

Guinea Bissau Health Bulletin

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Guinea Bissau Health Bulletin

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.